Hidehito Matsubara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hidehito Matsubara has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Akira Yamagata
Department of Nephrology and Endocrinology, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan
1 shared publicationAyami Naito
Department of Medicine, Self-Defense Forces Sendai Hospital, Sendai, Japan
1 shared publicationHiroo Kumagai
Department of Nephrology and Endocrinology, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan
1 shared publicationHiroomi Hashizume
Department of Medicine, Self-Defense Forces Sendai Hospital, Sendai, Japan
1 shared publicationJun Sugisawa
Department of Medicine, Self-Defense Forces Sendai Hospital, Sendai, Japan
1 shared publicationKeita Saito
Department of Medicine, Self-Defense Forces Sendai Hospital, Sendai, Japan
1 shared publication
Latest Publications
- 3 September 2022
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 26 (12) , 1240-1241
Purple urine bag syndrome
- 3 September 2022
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 26 (12) , 1240-1241
Purple urine bag syndrome
- 15 April 2020
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 204 (8) , 2043-2052
PEPITEM/Cadherin 15 Axis Inhibits T Lymphocyte Infiltration and Glomerulonephritis in a Mouse Model of Systemic Lupus Erythematosus
Control of lymphocyte infiltration in kidney is a potential therapeutic strategy for lupus nephritis, considering that control of lymphocyte migration by sphingosine 1 phosphate has been implicated in inflammation-related pathology. The peptide inhibitor of the transendothelial migration (PEPITEM)/cadherin (CDH) 15 axis was recently reported to promote sphingosine 1 phosphate secretion. In this study, we investigated whether CDH15 is expressed in the kidney of MRL/lpr mice and whether lymphocyte infiltration is suppressed by exogenously administered PEPITEM. Mice (18 wk old) were randomized into 4-wk treatment groups that received PEPITEM or PBS encapsulated in dipalmitoylphosphatidylcholine liposomes. Enlargement of the kidney, spleen, and axillary lymph nodes was suppressed by PEPITEM treatment, which also blocked infiltration of double-negative T lymphocytes into the kidney and glomerular IgG/C3 deposition, reduced proteinuria, and increased podocyte density. Immunohistochemical analysis revealed that the PEPITEM receptor CDH15 was expressed on vascular endothelial cells of glomeruli and kidney arterioles, skin, and peritoneum in lupus mice at 22 wk of age but not in 4-wk-old mice. These results suggest that PEPITEM inhibits lymphocyte migration and infiltration into the kidney, thereby preserving the kidney structure and reducing proteinuria. Thus, PEPITEM administration may be considered as a potential therapeutic tool for systemic lupus erythematosus.
- 15 April 2020
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 204 (8) , 2043-2052
PEPITEM/Cadherin 15 Axis Inhibits T Lymphocyte Infiltration and Glomerulonephritis in a Mouse Model of Systemic Lupus Erythematosus
Control of lymphocyte infiltration in kidney is a potential therapeutic strategy for lupus nephritis, considering that control of lymphocyte migration by sphingosine 1 phosphate has been implicated in inflammation-related pathology. The peptide inhibitor of the transendothelial migration (PEPITEM)/cadherin (CDH) 15 axis was recently reported to promote sphingosine 1 phosphate secretion. In this study, we investigated whether CDH15 is expressed in the kidney of MRL/lpr mice and whether lymphocyte infiltration is suppressed by exogenously administered PEPITEM. Mice (18 wk old) were randomized into 4-wk treatment groups that received PEPITEM or PBS encapsulated in dipalmitoylphosphatidylcholine liposomes. Enlargement of the kidney, spleen, and axillary lymph nodes was suppressed by PEPITEM treatment, which also blocked infiltration of double-negative T lymphocytes into the kidney and glomerular IgG/C3 deposition, reduced proteinuria, and increased podocyte density. Immunohistochemical analysis revealed that the PEPITEM receptor CDH15 was expressed on vascular endothelial cells of glomeruli and kidney arterioles, skin, and peritoneum in lupus mice at 22 wk of age but not in 4-wk-old mice. These results suggest that PEPITEM inhibits lymphocyte migration and infiltration into the kidney, thereby preserving the kidney structure and reducing proteinuria. Thus, PEPITEM administration may be considered as a potential therapeutic tool for systemic lupus erythematosus.
- 20 September 2019
- Published by Wiley in The Journal of Dermatology
- Vol. 47 (1) , E32-E33
Herpes zoster duplex in a patient with influenza A and bacterial superinfection
- 20 September 2019
- Published by Wiley in The Journal of Dermatology
- Vol. 47 (1) , E32-E33
Herpes zoster duplex in a patient with influenza A and bacterial superinfection